… be effective against SARS-CoV-2, the etiological agent of COVID-19. Hydroxychloroquine, …
syndrome coronavirus 2 (SARS-CoV-2), causes the Coronavirus Disease 2019 (COVID-19), …

… SARS-CoV-2 and SARS-CoV, the structure and function prediction of SARS-CoV-2
genome … protein were mainly based on those researches on homology protein in SARS-CoV. …

… (14) In this study, we systematically evaluated the antiviral potential of artemisinins against
SARS-CoV-2 in vitro and discovered that artesunate could inhibit SARS-CoV-2 replication in …

… In December 2019, a novel SARS-CoV-2 coronavirus … all been successful in inhibiting
SARS-CoV-2 in vitro. The initial … The results of clinical trials point to the potential clinical efficacy …

… between SARS-CoV and SARS-CoV2, it remains to know whether the potential neuroinvasion
of SARS-CoV-2 plays a role in the acute respiratory failure of patients with COVID-19. …

… was quickly discovered to be caused by a coronavirus later named severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) [1], which belongs to the β coronavirus family. It is …

… 2 persons with confirmed cases of symptomatic COVID-19 after their exposure to a potentially
presymptomatic person who was later diagnosed with laboratory-confirmed COVID-19. …

… ), known to cause the disease COVID-19, was declared a … potential of plants and natural
products to inhibit coronavirus … , which may have potential activity against SARS-CoV-2. Due to …

… SARS-CoV-2 infection remain largely unknown. In this review, we attempt to discuss and
summarize possible mechanisms of SARS-CoV-2-… cause of fatality in SARS-CoV-2 infection, we …

… coronavirus 2 (SARS-CoV-2) variants of concern (VOC) poses a major threat on international
public health as the rapid change of the SARS-CoV-2 … clinical management [1, 2]. Yet, it is …